Myofibrillar myopathies: State of the art, present and future challenges

A Béhin1, E Salort-Campana2, K Wahbi3

  • 1Centre de référence de pathologie neuromusculaire Paris-Est, groupe hospitalier Pitié-Salpêtrière, institut de Myologie, AP-HP, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.

Revue Neurologique
|September 7, 2015
PubMed

Insights

Myofibrillar myopathies (MFM) are rare genetic muscle diseases. This review covers six key genes and highlights the diagnostic challenges and importance of genetic testing in MFM.

Area of Science:

  • Neurology
  • Genetics
  • Histopathology

Background:

  • Myofibrillar myopathies (MFM) are a group of inherited muscle disorders characterized by specific histological findings.
  • Key features include abnormal protein aggregation, vacuoles, and Z-disk disorganization.
  • The genetic basis of MFM is complex, involving multiple genes, with evolving diagnostic criteria.

Purpose of the Study:

  • To review current knowledge on the six main genes associated with MFM.
  • To present clinical and genetic findings from French reference centers.
  • To emphasize diagnostic challenges and the role of genetic testing.

Main Methods:

  • Review of existing literature on MFM genetics and clinical presentations.
  • Analysis of patient data from two French reference centers (Paris and Marseilles).
  • Focus on histological features, muscle imaging, and genetic testing.

Main Results:

  • Six genes (DES, CRYAB, LDB3/ZASP, MYOT, FLNC, BAG3) are primarily implicated in MFM.
  • Other genetic entities, like FHL1 myopathy and titin-related myopathies, are increasingly recognized as part of the MFM spectrum.
  • Muscle imaging plays a crucial role due to potential focal histological lesions.

Conclusions:

  • Accurate diagnosis of MFM can be challenging due to variable presentation and focal pathology.
  • Systematic genetic testing is essential for patients with typical histological findings.
  • Continued research and data sharing from reference centers are vital for understanding MFM.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.1K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.5K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
7.2K
Classification of Skeletal Muscle Fibers01:48

Classification of Skeletal Muscle Fibers

Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
60.3K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K